RISK-FACTORS FAR INTRACRANIAL HEMORRHAGE IN OUTPATIENTS TAKING WARFARIN

被引:729
作者
HYLEK, EM
SINGER, DE
机构
[1] Massachusetts General Hospital, Boston, MA
[2] General Internal Medicine Unit, Massachusetts General Hospital, Boston, MA 02114
关键词
D O I
10.7326/0003-4819-120-11-199406010-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To explore the rational use of anticoagulants, especially among the elderly, balancing antithrombotic efficacy and risk for hemorrhage. Previous prospective studies have not provided powerful assessments of risk factors for intracranial hemorrhage, the dominant complication in reversing the anticoagulant decision. Design: Case-control analysis. Setting: A large general hospital and its anticoagulant therapy unit. Patients: 121 consecutive adult patients taking warfarin who were hospitalized with intracranial hemorrhage were each matched to three contemporaneous controls randomly selected from among outpatients managed by our hospital anticoagulant therapy unit. Results: 77 patients had intracerebral hemorrhage (46% fatal) and 44 had subdural hemorrhage (20% fatal). The prothrombin time ratio (PTR) was the dominant risk factor for intracranial hemorrhage. For each 0.5 increase in PTR over the entire range, the risk for intracerebral hemorrhage doubled (odds ratio, 2.1; 95% CI, 1.4 to 2.9). For subdural hemorrhage, the risk was unchanged over the PTR range from 1.0 to 2.0 but rose dramatically above a PTR of 2.0 (approximate international normalized ratio, 4.0). Age was the only other significant independent risk factor for subdural hemorrhage (odds ratio, 2.0 per decade; CI, 1.3 to 3.1). For intracerebral hemorrhage, age was of borderline significance (odds ratio, 1.3 per decade; CI, 1.0 to 1.6) after controlling for PTR and the two other independent risk factors: history of cerebrovascular disease (odds ratio, 3.1; CI, 1.7 to 5.6) and presence of a prosthetic heart valve (odds ratio, 2.8; CI, 1.3 to 5.8). Conclusions: The results emphasize the importance of maintaining the prothrombin time ratios under 2.0 and the need for especially careful use of warfarin in the elderly.
引用
收藏
页码:897 / 902
页数:6
相关论文
共 37 条
  • [1] LOBAR HEMORRHAGE IN THE ELDERLY - THE UNDIMINISHING IMPORTANCE OF HYPERTENSION
    BRODERICK, J
    BROTT, T
    TOMSICK, T
    LEACH, A
    [J]. STROKE, 1993, 24 (01) : 49 - 51
  • [2] RELIANCE ON PROTHROMBIN TIME RATIOS CAUSES SIGNIFICANT ERRORS IN ANTICOAGULATION THERAPY
    BUSSEY, HI
    FORCE, RW
    BIANCO, TM
    LEONARD, AD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (02) : 278 - 282
  • [3] CANADIAN ATRIAL-FIBRILLATION ANTICOAGULATION (CAFA) STUDY
    CONNOLLY, SJ
    LAUPACIS, A
    GENT, M
    ROBERTS, RS
    CAIRNS, JA
    JOYNER, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) : 349 - 355
  • [4] WARFARIN IN THE PREVENTION OF STROKE ASSOCIATED WITH NONRHEUMATIC ATRIAL-FIBRILLATION
    EZEKOWITZ, MD
    BRIDGERS, SL
    JAMES, KE
    CARLINER, NH
    COLLING, CL
    GORNICK, CC
    KRAUSESTEINRAUF, H
    KURTZKE, JF
    NAZARIAN, SM
    RADFORD, MJ
    RICKLES, FR
    SHABETAI, R
    DEYKIN, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) : 1406 - 1412
  • [5] RISK-FACTORS FOR COMPLICATIONS OF CHRONIC ANTICOAGULATION - A MULTICENTER STUDY
    FIHN, SD
    MCDONELL, M
    MARTIN, D
    HENIKOFF, J
    VERMES, D
    KENT, D
    WHITE, RH
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (07) : 511 - 520
  • [6] FLEISS JL, 1981, STATISTICAL METHODS, P123
  • [7] INTRACEREBRAL HEMATOMAS DURING ANTICOAGULANT TREATMENT
    FRANKE, CL
    DEJONGE, J
    VANSWIETEN, JC
    DECOUL, AAWO
    VANGIJN, J
    [J]. STROKE, 1990, 21 (05) : 726 - 730
  • [8] COST-EFFECTIVENESS OF PRIMARY STROKE PREVENTION IN ATRIAL-FIBRILLATION - SWEDISH NATIONAL PERSPECTIVE
    GUSTAFSSON, C
    ASPLUND, K
    BRITTON, M
    NORRVING, B
    OLSSON, B
    MARKE, LA
    [J]. BRITISH MEDICAL JOURNAL, 1992, 305 (6867) : 1457 - 1460
  • [9] HART RG, 1984, STROKE, V15, P779